Innovation in Namibia: Preserving private health insurance and HIV/AIDS treatment

Health Affairs

Volumn 28, Issue 6, 2009, Pages 1799-1806

  Schellekens, Onno P ^a   De Beer, Ingrid ^a   Lindner, Marianne E ^a   Van Vugt, Michele ^a   Schellekens, Peter ^a   De Wit, Tobias Floris Rinke ^a  

^a PharmAccess Foundation   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CONFERENCE PAPER; HEALTH CARE QUALITY; HEALTH INSURANCE; HEALTH SERVICE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MEDICAL ASSISTANT; NAMIBIA;

ACQUIRED IMMUNODEFICIENCY SYNDROME; GIFT GIVING; HIV INFECTIONS; HUMANS; INSURANCE, HEALTH; NAMIBIA; ORGANIZATIONAL INNOVATION; PRIVATE SECTOR; QUALITY OF HEALTH CARE; SOCIOECONOMIC FACTORS;

EID: 77952199172     PISSN: 02782715     EISSN: 15445208     Source Type: Journal    
DOI: 10.1377/hlthaff.28.6.1799     Document Type: Conference Paper

References (27)

1. United Nations Development Program Human devdopment indicators. In: Human development report 2007/2008. Fighting climate change: human solidarity in a divided world [Internet]. New York UNDP; 2007 [cited 2009 Aug 26]. Available from: http://hdr.undp.org/en/media/ HDR-20072008-EN-Indicator-tables.pdf
2. World Health Organization. World health statistics [Internet]. Geneva: WHO; [cited 2008 Oct 26]. Available from http://www.who.int/whosis/ data
3. Republic of Namibia, Ministry of Health and Social Services. United Nations General Assembly Special Session (UNGASS) country report. Reporting period April 2006-March 2007 [Internet]. Windhoek Ministry of Health and Social Services; [cited 2009 Aug 26]. Available from http://data.unaids.org/pub/Report/ 2008/ namibia-2008-country-progress-report-en.pdf
4. World Health Organization/UNAIDS. Namibia: epidemiological fact sheet on HIV and AIDS. Geneva: WHO/UNAIDS; 2008 Sep.
5. Fedey F, DeBeer I, Rinke de Wit T, vander Gaag J. The health insurance industry in Namibia: baseline report [Internet]. Boston: Boston University, Center for International Devdopment; Amsterdam Institute for International Development; and PharmAccess Foundation; 2006 Jun [cited 2009 Aug 26]. Available from http://sph.bu.edu/cihd/images/stories/scfiles/cih/final-namibia-insurance- situation-june-2006.pdf
6. United States President's Emergency Plan for AIDS Relief [Internet]. Washington: PEPFAR; [cited 2009 Feb 16]. Available from http://www .pepfar.org
7. Global Fund to Fight AIDS, Tuberculosis, and Malaria [Internet]. Geneva: Global Fund; c2009 [cited 2009 Feb 16]. Available from http://www .theglobalfund.org
8. Cutler DM, Gruber J. The effect of Medicaid expansions on public insurance, private insurance, and redistribution. Am Econ Rev. 1996;86(2): 378-83.
9. Kronick R, Gilmer T. Insuring low-income adults: does public coverage crowd out private? Health Aff (Millwood). 2002;21(1):225-39.
10. van der Gaag J, Stimac V. Towards a new paradigm for health sector development. Amsterdam: Amsterdam Institute for International Development; 2008 Sep.
11. World Bank. Better health in Africa, experience and lessons learned. Washington: World Bank 1994.
12. MyHealth Administrators. Unpublished reports provided to PharmAccess Foundatioa Windhoek MyHealth Administrators; 2007.
13. Namibia Medical Aids Federatioa Conference management report. Windhoek NAMAF; 2005.
14. This paper discusses only private formal-sector workers. It does not discuss civil servants, who are insured under a separate arrangement.
15. Hohmann J, Skolnic RA. Options and scenarios for HIV/AIDS risk cover for low-income employees within NABCOA member companies in Namibia. Report on the feasibility study, October 18-November 25, 2004. Windhoek: Namibia Business Coalition on AIDS; 2004.
16. The donor is PharmAccess Foundation, a Dutch not-for-profit organization engaged in strengthening health systems in sub-Saharan Africa. The PharmAccess project supporting the Namibian innovation is called the Okambilimbili project (which, in the Oshivambo language, means "butterfly," as a sign of positive change).
17. Members of employer groups who could not afford Product 2 could buy Product 1. In that case, the employer paid the full premium.
18. This concerns quality improvement within the private system A comparison of the quality and price of public care is not available.
19. The donor, PharmAccess, provided external quality assurance through the database.
20. Keiser O, Anastos K, Schechter M, Balestre E, Myer L, Boulle A, et al. Antiretroviral therapy in resource-limited settings 1996 to 2006: patient characteristics, treatment regimens, and monitoring in sub-Saharan Africa, Asia, and Latin America. Trop Med Int Health. 2008;13(7):870-9.
21. Unpublished data from the MyHealth disease management program, provided to PharmAccess Foundation, 2007.
22. Unpublished data from the Health Is Vital Risk Equalization Fund, provided to PharmAccess, 2009.
23. Carrin G. Community-based health insurance schemes in developing countries: facts, problems, and perspective. Geneva: WHO; 2003.
24. Preker AS, Carrin G, Dror D, Jakab M, Hsiao W Arhin-Tenkorang D. Effectiveness of community health financing in meeting the cost of illness. Bull World Health Organ. 2002;80(2):143-50.
25. Litvack J, Bodart C. User fees plus quality equals improved access to health care: results of a field experiment in Cameroon. Soc Sci Med. 1993;37 (3):369-83.
26. Asfaw A, Gustafsson-Wright E, van der Gaag J. Willingness to pay for health insurance: an analysis of the potential market for new low-cost health insurance products in Namibia. Amsterdam Amsterdam Institute for International Development; forthcoming.
27. See, for example, Jack W. Health insurance reform in four Latin-American countries: theory and practice. Washington: World Bank 2000.